本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Epizyme Inc.

1.47
0.0000
成交量:- -
成交额:3,275.66万
市值:2.47亿
市盈率:-0.91
高:1.47
开:1.47
低:1.47
收:1.47
数据加载中...
2021/02/23

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/23

重要事件披露

8-K - Current report
2020/11/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

重要事件披露

8-K - Current report
2020/10/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report
2020/06/03

重要事件披露

8-K - Current report
2020/05/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/04

重要事件披露

Current report, items 2.02 and 9.01
2020/04/03

重要事件披露

8-K - Current report
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/24

重要事件披露

Current report, items 2.02 and 9.01
2020/02/21

超过5%披露

[Amend] General statement of acquisition of beneficial ownership